Find investors
← Back to all investors
JR
ResearchedAngel Investors

Jarret Rutstein

Senior Associate

Angel InvestorsSeed Round
Pitch Jarret

Get their honest, personalized take on your startup.

Sign in to pitch Jarret

At a glance

Full Name
Jarret Rutstein
Title
Principal *(current, A&M Capital Partners; previously Vice President at Angeles Equity Partners)*
Firm
A&M Capital Partners (Alvarez & Marsal Capital) — current; Angeles Equity Partners — 2018–2022
Firm Type
Private equity (control-oriented buyout) — not an angel/seed investor. *(The stub classification of "Angel Investors / Seed Round" appears to be an aggregator error; both firms make control investments in established companies.)*
Investment Stage
Control-oriented buyouts / lower- and middle-market private equity
Check Size
Not publicly disclosed (institutional PE equity checks, not seed-stage)
Target Company Profile
Established, control-acquirable operating companies — industrials and operationally complex businesses (at Angeles, "industrial sub-sectors")
Sector Focus
Industrials, business/facilities services, healthcare-adjacent services; broadly multi-industry control investments
Geographic Focus
United States
Location
Greater New York City / White Plains, NY area (A&M Capital is headquartered in Greenwich, CT); previously Los Angeles, CA (Angeles Equity)

Background

Jarret Rutstein is a private equity investor, currently a Principal at A&M Capital Partners (the private-equity arm of Alvarez & Marsal). He began his career in the Healthcare Investment Banking group at Bank of America Merrill Lynch (analyst, roughly 2014–2016), then moved into private equity as an Associate at A&M Capital Partners, where he evaluated, executed, and managed control-oriented investments across multiple industries.

In April 2018 he joined Angeles Equity Partners, a Los Angeles–based private equity firm specializing in control investments and operational transformation of industrial businesses. He spent roughly four years there (2018–2022), rising to Vice President and focusing on "control-oriented investments across a wide range of industrial sub-sectors." During this period the firm publicly framed his hire as "a high caliber addition" expected to play an integral role in its growth.

In 2022 he rejoined A&M Capital Partners, where he is now a Principal continuing to focus on control-oriented private equity investments. (Some third-party databases still list his title as Vice President; the firm's own team page lists Principal.)

He holds a Master of Finance from the MIT Sloan School of Management and a BA in Political Economy from Tulane University.

Investment Thesis & Focus

  • Invests via control-oriented private equity, not seed/angel checks — i.e., majority acquisitions of established operating companies rather than early-stage venture bets.
  • At Angeles Equity, focus was explicitly on industrial sub-sectors and operational transformation/value-creation in those businesses.
  • At A&M Capital Partners, continues to pursue control investments across multiple industries, leveraging Alvarez & Marsal's operational/restructuring heritage.
  • Sector experience spans industrials, business and facilities services, and healthcare-related services (reflecting his healthcare investment-banking start and the Xanitos deal).
  • No publicly published personal "thesis" statement is available; his focus is best inferred from his firms' control-buyout strategies and his deal history.

Notable Investments

  • Xanitos, Inc. — National provider of environmental/EVS services (hospital housekeeping, patient transport, and linen services) to hospitals and acute-care settings. Acquired by Angeles Equity Partners in June 2021 (Facilities Management sub-sector, in partnership with the founder); reported exit in 2025. Rutstein publicly promoted this acquisition while at Angeles Equity, indicating involvement.
  • Broader Angeles Equity Partners industrial-services portfolio during his 2018–2022 tenure and A&M Capital Partners control investments thereafter — specific individual deal attributions beyond Xanitos are not publicly itemized for him by name.

Unlock the full research

Get how to approach them, recent activity, sources, contact links — plus pitch their AI twin for a candid read on your raise.

One-time. Stays unlocked for you.